Nautilus Biotechnology

NAUTNasdaq United States Industrials Biotechnology: Laboratory Analytical Instruments

Market cap

$114.542 M

$0.90 +1.58%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$59.0M

Loss-making

Shares outstanding

127,255,223

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Laboratory Analytical Instruments — ranked by market cap

All 22 →

#14QuanterixQTRX$189.8M
#15SeerSEER$119.3M
#16Nautilus BiotechnologyNAUT$114.5M
#17Rapid Micro BiosystemsRPID$79.9M
#18Circle8 GroupCIRC$65.1M

Where these numbers come from

Share counts and financials for Nautilus Biotechnology are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.